Agilent Technologies Inc.
(NYSE: A) today announced the opening of a new facility in Mumbai, India, dedicated to developing integrated, end-to-end workflow solutions for supporting diversified end markets---including pharma, biopharma,and food testing.
The Agilent CoE in Mumbai is a state-of-the-art laboratory established with the purpose ofmeeting the increasing demand for next generation lean laboratories, delivering higher productivity, more efficiency, and providing higher-quality data. This new CoE will also enable a strong, local touch point for Agilent customers in the region to interact with well-qualified subject matter experts, representing Agilent’s entire portfolio range.
The facility is equipped with Agilent’s new products, software, and chemistries providing a wide range of application support to life science and applied markets. Agilent has strong focus on skills development activities, this CoE will offer customers comprehensive training and hands-on experience of instruments, lab informatics, good laboratory practices, and advanced analytical workflows.
Agilent continues to strengthen its portfolio throughR&D investments and M&As, incorporating new capabilities and highly differentiated products. The western region of India has strong potential and is an area of focus for Agilent. This CoEinvestment is strategically intended to build a conducive environment where R&D expertise can be appliedand developed. Furthermore, the scientific community will have the opportunity for collaboration to potentially achieve extraordinary scientific outcomes. The new laboratory will also support a platform for customer training on new applications, as well as solutions development.
“This new CoE at Mumbai is creatively-designed with the latest technology offerings, integrated software, and related services to ensure we can deliver trusted answers to our customers,” said Bharat Bhardwaj, country manager for Agilent India.